Goldman Laboratories' Liposomal NAD+ Wins Nourish Award for Metabolic Health Innovation

LONDON - Oct. 2, 2025 - PRLog -- Goldman Laboratories proudly announces that its Liposomal NAD+, formulated with the patented Biomimetic Liposome – OptimCell encapsulation, has been awarded the Nourish Award for Best Metabolic and Weight Management Product. The award recognises excellence in nutrition and wellness, highlighting products that demonstrate innovation, efficacy, and a measurable impact on health.

This recognition reflects Goldman Laboratories' commitment to advancing nutraceutical science. Liposomal NAD+ is designed to support individuals seeking improved metabolic health, sustained energy, and balanced weight management. By combining cutting-edge delivery technology with a focus on cellular optimisation, the product delivers meaningful results for consumers who prioritise health and longevity.

At the core of this innovation is the Biomimetic Liposome – OptimCell encapsulation, a patented system engineered to mimic natural cell membranes. This advanced encapsulation enhances the stability and absorption of NAD+, a molecule vital for cellular energy production and metabolic function. The result is superior bioavailability, ensuring that the body receives and utilises the nutrient more effectively than conventional formulations.

NAD+ is widely recognised for its essential role in energy metabolism, DNA repair, and cellular regeneration. However, one of the challenges with traditional supplementation is poor absorption. Goldman Laboratories addresses this issue with its patented encapsulation technology, giving consumers a reliable and effective solution to support their metabolic goals.

The award-winning product offers multiple benefits, including sustained energy levels, enhanced mitochondrial function, improved metabolic efficiency, and support for healthy weight management. By promoting optimal cellular activity, Liposomal NAD+ contributes not only to physical vitality but also to long-term health and wellness.

The Nourish Award judges praised the product's scientific foundation, innovative delivery system, and potential to transform the supplement landscape. Their recognition underlines Goldman Laboratories' role as a leader in developing advanced nutraceuticals that bridge the gap between science and everyday wellness.

"Our mission has always been to provide scientifically validated products that deliver real results," said Jordi Mascio, Director of Goldman Laboratories Ltd. "The recognition of our Liposomal NAD+ with this award is a strong validation of the years of research and development we have dedicated to Biomimetic Liposome and OptimCell technology."

Goldman Laboratories continues to develop products at the forefront of nutritional science, focusing on innovations that enhance absorption, effectiveness, and user experience. The success of Liposomal NAD+ demonstrates how advanced encapsulation technologies can unlock the true potential of nutrients, offering consumers trusted solutions for their health goals.

For more information about Liposomal NAD+ and other innovations, visit:
http://goldmanlaboratories.com